MicroRNA profiling during mouse ventricular maturation: a role for miR-27 modulating Mef2c expression

被引:94
作者
Chinchilla, Ana [1 ]
Lozano, Estefania [1 ]
Daimi, Houria [1 ]
Esteban, Francisco J. [2 ]
Crist, Colin [3 ]
Aranega, Amelia E. [1 ]
Franco, Diego [1 ]
机构
[1] Univ Jaen, Cardiovasc Dev Grp, Dept Expt Biol, Jaen 23071, Spain
[2] Univ Jaen, Dept Expt Biol, Syst Biol Grp, Jaen 23071, Spain
[3] Inst Pasteur, Dept Dev Biol, CNRS, URA 2578, F-75724 Paris, France
关键词
MicroRNAs; Cardiogenesis; Microarrays; Mef2c; miR-27b; TRANSCRIPTION FACTOR; CARDIAC DEVELOPMENT; CHAMBER FORMATION; HEART; GENE; MORPHOGENESIS; HYPERTROPHY; MECHANISMS; CONDUCTION; MIR-133;
D O I
10.1093/cvr/cvq264
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Aims Non-coding RNA has been recently demonstrated to be a novel mechanism for modulation of gene expression at the post-transcriptional level. The importance of microRNAs in the cardiovascular system is now apparent. Mutations of distinct microRNAs have provided evidence for fundamental roles of microRNAs during cardiovascular development. However, there is limited information about global microRNA profiles during mouse heart development. In this study, we have gained insight from the expression profiles of microRNAs during mouse ventricular development by microarray and qRT-PCR analysis. Methods and results Our microarray analysis reveals that relatively few microRNAs display either increasing or decreasing expression profiles during ventricular chamber formation. Interestingly, most of the differentially expressed microRNAs display a rather discrete peak of expression at particular developmental stages. Furthermore, we demonstrate that microRNA-27b (miR-27b) displays an overt myocardial expression during heart development and that the transcription factor-encoding gene Mef2c is an miR-27b target. Conclusion Our data present a comprehensive profile of microRNA expression during ventricular maturation, providing an entry point for investigation of the functional roles of the most abundantly and differentially expressed microRNAs during cardiogenesis.
引用
收藏
页码:98 / 108
页数:11
相关论文
共 37 条
[1]
Partition function and base pairing probabilities of RNA heterodimers [J].
Bernhart, Stephan H. ;
Tafer, Hakim ;
Mueckstein, Ulrike ;
Flamm, Christoph ;
Stadler, Peter F. ;
Hofacker, Ivo L. .
ALGORITHMS FOR MOLECULAR BIOLOGY, 2006, 1 (1)
[2]
Transcriptional regulation of vertebrate cardiac morphogenesis [J].
Bruneau, BG .
CIRCULATION RESEARCH, 2002, 90 (05) :509-519
[3]
MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice [J].
Callis, Thomas E. ;
Pandya, Kumar ;
Seok, Hee Young ;
Tang, Ru-Hang ;
Tatsuguchi, Mariko ;
Huang, Zhan-Peng ;
Chen, Jian-Fu ;
Deng, Zhongliang ;
Gunn, Bronwyn ;
Shumate, Janelle ;
Willis, Monte S. ;
Selzman, Craig H. ;
Wang, Da-Zhi .
JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (09) :2772-2786
[4]
MicroRNA-133 controls cardiac hypertrophy [J].
Care, Alessandra ;
Catalucci, Daniele ;
Felicetti, Federica ;
Bonci, Desiree ;
Addario, Antonio ;
Gallo, Paolo ;
Bang, Marie-Louise ;
Segnalini, Patrizia ;
Gu, Yusu ;
Dalton, Nancy D. ;
Elia, Leonardo ;
Latronico, Michael V. G. ;
Hoydal, Morten ;
Autore, Camillo ;
Russo, Matteo A. ;
Dorn, Gerald W., II ;
Ellingsen, Oyvind ;
Ruiz-Lozano, Pilar ;
Peterson, Kirk L. ;
Croce, Carlo M. ;
Peschle, Cesare ;
Condorelli, Gianluigi .
NATURE MEDICINE, 2007, 13 (05) :613-618
[5]
Gene regulation by microRNAs [J].
Carthew, RW .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2006, 16 (02) :203-208
[6]
Revealing a role of microRNAs in the regulation of the biological clock [J].
Cheng, Hai-Ying Mary ;
Obrietan, Karl .
CELL CYCLE, 2007, 6 (24) :3034-3038
[7]
MicroRNAs are aberrantly expressed in hypertrophic heart - Do they play a role in cardiac hypertrophy? [J].
Cheng, Yunhui ;
Ji, Ruirui ;
Yue, Junming ;
Yang, Jian ;
Liu, Xiaojun ;
Chen, He ;
Dean, David B. ;
Zhang, Chunxiang .
AMERICAN JOURNAL OF PATHOLOGY, 2007, 170 (06) :1831-1840
[8]
Chinchilla A, 2009, TRENDS DEV BIOL, V4, P1
[9]
Chinchilla A, 2010, SHAPING HEART DEV DI
[10]
Chinchilla Ana, 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P101